J Andrew Jones

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Topics

Escherichia Coli

Structural Basis

Wastewater Treatment

Regulatory T Cells

Top Venues

Applied and environmental microbiology

Biotechnology progress

Biotechnology and bioengineering

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyang Xu, Andor J Kiss, J Andrew Jones, Matthew Stephen McMurray, Haifei Shi
Effect of oral tryptamines on the gut microbiome of rats-a preliminary study. PeerJ 12 (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Fiona C Kanis, Caroline N Broude, Elle B Hellwarth, William J Gibbons, Abhishek K Sen, Alexandra M Adams, Xin Wang, J Andrew Jones
Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities. Biotechnology progress (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Mengyang Xu, Andor J Kiss, J Andrew Jones, Matthew Stephen McMurray, Haifei Shi
Effect of oral tryptamines on the gut microbiome of rats-a preliminary study. PeerJ 12 (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Nicholas A Kaplan, Khondokar Nowshin Islam, Fiona C Kanis, Jack R Verderber, Xin Wang, J Andrew Jones, Mattheos A G Koffas
Simultaneous glucose and xylose utilization by an Escherichia coli catabolite repression mutant. Applied and environmental microbiology 90 (2) (2024)
Jessica E Flower, William J Gibbons, Alexandra M Adams, Xin Wang, Caroline N Broude, J Andrew Jones
"Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli". Biotechnology and bioengineering (2023)
William J Gibbons, Madeline G McKinney, Philip J O'Dell, Brooke A Bollinger, J Andrew Jones
Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use? Bioengineered 12 (1) (2022)
Brady F Cress, J Andrew Jones, Daniel C Kim, Quentin D Leitz, Jacob A Englaender, Shannon M Collins, Robert J Linhardt, Mattheos A G Koffas
Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes in Escherichia coli. Nucleic acids research 44 (9) (2016)